| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lichen Planus | FAERS: 1 | US FAERS | |
| 2 | Pancreatitis | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Pancytopenia | FAERS: 1 | US FAERS | |
| 4 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 5 | Abdominal discomfort | Canada Vigilance: 2 | Canada Vigilance | |
| 6 | Acute Coronary Syndrome | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Acute kidney injury | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Angioedema | Canada Vigilance: 3 | Canada Vigilance | |
| 9 | Anxiety | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Arthralgia | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Blood creatinine increased | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Blood urea increased | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Bronchospasm | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Chest discomfort | Canada Vigilance: 3 | Canada Vigilance | |
| 16 | Dehydration | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Depressed mood | Canada Vigilance: 2 | Canada Vigilance | |
| 18 | Dizziness | Canada Vigilance: 3 | Canada Vigilance | |
| 19 | Drug ineffective | Canada Vigilance: 2 | Canada Vigilance | |
| 20 | Dry skin | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Erectile dysfunction | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Fatigue | Canada Vigilance: 3 | Canada Vigilance | |
| 23 | Head discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Headache | Canada Vigilance: 4 | Canada Vigilance | |
| 25 | Hypersensitivity | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Hypersomnia | Canada Vigilance: 1 | Canada Vigilance | |
| 27 | Hypotension | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Joint swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Malaise | Canada Vigilance: 2 | Canada Vigilance | |
| 30 | Muscle tightness | Canada Vigilance: 2 | Canada Vigilance | |
| 31 | Myalgia | Canada Vigilance: 2 | Canada Vigilance | |
| 32 | Myocardial Infarction | Canada Vigilance: 1 | Canada Vigilance | |
| 33 | Nausea | Canada Vigilance: 4 | Canada Vigilance | |
| 34 | Neutropenia | Canada Vigilance: 1 | Canada Vigilance | |
| 35 | Peripheral swelling | Canada Vigilance: 2 | Canada Vigilance | |
| 36 | Product quality issue | Canada Vigilance: 1 | Canada Vigilance | |
| 37 | Product substitution issue | Canada Vigilance: 3 | Canada Vigilance | |
| 38 | Pseudomyopia | Canada Vigilance: 1 | Canada Vigilance | |
| 39 | Pulmonary Fibrosis | Canada Vigilance: 2 | Canada Vigilance | |
| 40 | Sinusitis | Canada Vigilance: 1 | Canada Vigilance | |
| 41 | Somnolence | Canada Vigilance: 1 | Canada Vigilance | |
| 42 | Tachycardia | Canada Vigilance: 2 | Canada Vigilance | |
| 43 | Thirst | Canada Vigilance: 1 | Canada Vigilance | |
| 44 | Tinnitus | Canada Vigilance: 1 | Canada Vigilance | |
| 45 | Urinary tract infection | Canada Vigilance: 1 | Canada Vigilance | |
| 46 | Vascular Diseases | 19864958 | CTD | |
| 47 | Weight decreased | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.